Chescapmanager’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Chescapmanager’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-103,521	Closed	-$9.32K	–	45
2024 Q1	$9.32K	Hold	103,521	–	–	﹤0.01%	42
2023 Q4	$10.9K	Hold	103,521	–	–	﹤0.01%	41
2023 Q3	$23.3K	Hold	103,521	–	–	﹤0.01%	41
2023 Q2	$27.1K	Hold	103,521	–	–	﹤0.01%	40
2023 Q1	$19K	Hold	103,521	–	–	﹤0.01%	43
2022 Q4	$21K	Hold	103,521	–	–	﹤0.01%	38
2022 Q3	$75K	Hold	103,521	–	–	0.02%	40
2022 Q2	$55K	Hold	103,521	–	–	0.01%	40
2022 Q1	$91K	Hold	103,521	–	–	0.01%	46
2021 Q4	$232K	Hold	103,521	–	–	0.03%	57
2021 Q3	$351K	Buy	+103,521	New	+$369K	0.05%	55

Other funds holding DNA.WS

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

JRCM

Jones Road Capital Management New York $55.3M AUM 29.97% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $190M AUM 36.38% 1-Year Est. Return

Chescapmanager's DNA.WS Position: Q2 2024 in Review

Chescapmanager sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q2 2024, closing a stake of 103,521 shares — an estimated $9.32K sold.

Chescapmanager first reported a position in DNA.WS in Q3 2021 and held it in 11 quarters. The position peaked at $351K in Q3 2021. 28 funds tracked by Wall St. Rank hold DNA.WS as of Q2 2024.

Chescapmanager reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q2 2024 after selling out during the quarter.
Chescapmanager sold 103,521 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q2 2024, an estimated $9.32K.
Chescapmanager first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q3 2021 and held it in 11 quarters.
Chescapmanager's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $351K in Q3 2021.
28 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q2 2024.

Based on Chescapmanager's 13F filing for Q2 2024, filed 14 Aug 2024.